347 related articles for article (PubMed ID: 19205989)
1. Independent component analysis for assessing therapeutic response in vitiligo skin disorder.
Fadzil MH; Norashikin S; Suraiya HH; Nugroho H
J Med Eng Technol; 2009; 33(2):101-9. PubMed ID: 19205989
[TBL] [Abstract][Full Text] [Related]
2. Computerised image analysis of vitiligo lesion: evaluation using manually defined lesion areas.
Nugroho H; Ahmad Fadzil MH; Shamsudin N; Hussein SH
Skin Res Technol; 2013 Feb; 19(1):e72-7. PubMed ID: 22233154
[TBL] [Abstract][Full Text] [Related]
3. Determination of skin repigmentation progression.
Nugroho H; Fadzil MH; Yap VV; Norashikin S; Suraiya HH
Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():3442-5. PubMed ID: 18002737
[TBL] [Abstract][Full Text] [Related]
4. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients.
Hofer A; Hassan AS; Legat FJ; Kerl H; Wolf P
Br J Dermatol; 2005 May; 152(5):981-5. PubMed ID: 15888156
[TBL] [Abstract][Full Text] [Related]
5. A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo.
Chimento SM; Newland M; Ricotti C; Nistico S; Romanelli P
J Drugs Dermatol; 2008 Mar; 7(3):258-63. PubMed ID: 18380207
[TBL] [Abstract][Full Text] [Related]
6. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.
Saraceno R; Nisticò SP; Capriotti E; Chimenti S
Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584
[TBL] [Abstract][Full Text] [Related]
7. Combination of microdermabrasion and 5-fluorouracil to induce repigmentation in vitiligo: an observational study.
Garg T; Chander R; Jain A
Dermatol Surg; 2011 Dec; 37(12):1763-6. PubMed ID: 21834930
[TBL] [Abstract][Full Text] [Related]
8. Digital image analysis vs. clinical assessment to evaluate repigmentation after punch grafting in vitiligo.
Linthorst Homan MW; Wolkerstorfer A; Sprangers MA; van der Veen JP
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e235-8. PubMed ID: 22621363
[TBL] [Abstract][Full Text] [Related]
9. A new digital image analysis system useful for surface assessment of vitiligo lesions in transplantation studies.
Van Geel N; Vander Haeghen Y; Ongenae K; Naeyaert JM
Eur J Dermatol; 2004; 14(3):150-5. PubMed ID: 15246939
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
[TBL] [Abstract][Full Text] [Related]
11. Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial.
Radakovic S; Breier-Maly J; Konschitzky R; Kittler H; Sator P; Hoenigsmann H; Tanew A
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):951-3. PubMed ID: 19496898
[TBL] [Abstract][Full Text] [Related]
12. Quantitative method for measuring therapeutic efficacy of the 308 nm excimer laser for vitiligo.
Oh TS; Lee O; Kim JE; Son SW; Oh CH
Skin Res Technol; 2012 Aug; 18(3):347-55. PubMed ID: 22092743
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of pimecrolimus 1% cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study.
Farajzadeh S; Daraei Z; Esfandiarpour I; Hosseini SH
Pediatr Dermatol; 2009; 26(3):286-91. PubMed ID: 19706089
[TBL] [Abstract][Full Text] [Related]
14. Update on skin repigmentation therapies in vitiligo.
Falabella R; Barona MI
Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo].
Rojas-Urdaneta JE; Poleo-Romero AG
Invest Clin; 2007 Mar; 48(1):21-31. PubMed ID: 17432541
[TBL] [Abstract][Full Text] [Related]
16. Dihydroxyacetone: a safe camouflaging option in vitiligo.
Rajatanavin N; Suwanachote S; Kulkollakarn S
Int J Dermatol; 2008 Apr; 47(4):402-6. PubMed ID: 18377610
[TBL] [Abstract][Full Text] [Related]
17. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
[TBL] [Abstract][Full Text] [Related]
18. An objective method for the assessment of vitiligo treatment.
Marrakchi S; Bouassida S; Meziou TJ; Turki H; Zahaf A
Pigment Cell Melanoma Res; 2008 Feb; 21(1):106-7. PubMed ID: 18353149
[No Abstract] [Full Text] [Related]
19. Simple quantitative assessment for repigmentation in vitiligo.
Sohail A; Vaqas B; Bodeker G; Ryan T
Int J Dermatol; 2012 Mar; 51(3):360-1. PubMed ID: 22348581
[No Abstract] [Full Text] [Related]
20. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.
Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM
Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
